LAB (Standard BioTools Inc.) is set to announce its Q2'26 results on July 30, time not specified. The earnings are expected to be disclosed at 8:00 AM ET (12:00 PM UTC).
For Q2'26, revenue estimate is 20.80 million USD with EPS (earnings per share) anticipated at (0.01) USD. Learn more details at .
Revenue & EPS values are provided in USD
| Q2'25Q3'25Q4'25Q1'26Q2'26 | |||||
| Revenue Reported21.76 M19.55 M23.80 M21.15 M— | Revenue Estimate39.82 M18.00 M18.50 M17.80 M20.80 M | Revenue Surprise-45.35%+8.62%+28.61%+18.80% | EPS Reported(0.05)(0.09)0.04(0.04) | EPS Estimate(0.07)(0.04)(0.05)(0.05)(0.01) | EPS Surprise+25.07%-107.69%+174.17%+14.29% |